Latest Period
Q1 2026
Security Snapshot
Alaunos Therapeutics, Inc. - Common stock (TCRT) Institutional Ownership
CUSIP: 98973P309
13F Institutional Holders and Ownership History from Q2 2024 to Q1 2026
Institutions Reporting
28
Shares (Excl. Options)
125,752
Price
$2.86
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common stock
- Symbol
- TCRT on Nasdaq
- Shares outstanding
- 2,198,384
- Price per share
- $2.86
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 125,752
- Total reported value
- $359,538
- % of total 13F portfolios
- 0%
- Share change
- +17,511
- Value change
- +$50,029
- Number of holders
- 28
- Price from insider filings
- $2.86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- TCRT - Alaunos Therapeutics, Inc. - Common stock is tracked under CUSIP 98973P309.
- 28 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 26 to 28 between Q4 2025 and Q1 2026.
- Reported value moved from $349,893 to $359,538.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 28 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 98973P309?
CUSIP 98973P309 identifies TCRT - Alaunos Therapeutics, Inc. - Common stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 98973P309:
Significant Owners of Alaunos Therapeutics, Inc. - Common stock (TCRT) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Postma Robert W | 9% | $615,372 | 199,796 | Postma Robert W | 24 Jun 2025 | |||
| Price Adrian | 8.6% | 0% | $491,559 | 189,061 | 0% | Price Adrian | 24 Feb 2026 |
As of 31 Mar 2026, 28 institutional investors reported holding 125,752 shares of Alaunos Therapeutics, Inc. - Common stock (TCRT). This represents 5.7% of the company’s total 2,198,384 outstanding shares.
Institutional Holders of Alaunos Therapeutics, Inc. - Common stock (TCRT) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 125,752 | $359,538 | +$50,029 | $2.86 | 28 |
| 2025 Q4 | 108,542 | $349,893 | +$139,293 | $3.23 | 26 |
| 2025 Q3 | 65,224 | $158,311 | -$15,260 | $2.41 | 24 |
| 2025 Q2 | 70,942 | $344,079 | +$2,573 | $4.85 | 25 |
| 2025 Q1 | 70,134 | $102,359 | -$2,277 | $1.47 | 25 |
| 2024 Q4 | 72,015 | $136,970 | -$361,475 | $1.90 | 28 |
| 2024 Q3 | 192,061 | $622,752 | +$549,975 | $3.22 | 28 |
| 2024 Q2 | 37 | $25 | +$25 | $0.68 | 3 |